NMR Secures $3.5 Million Convertible Note to Cut Debt and Bolster Working Capital

• A$3.5 million convertible note funding secured
• Part repayment of existing convertible note debt
• Convertible note convertible at discount if not redeemed in 6 months
• Potential dilution capped at approximately 6.5% of issued capital
• Funding within ASX Listing Rule 7.1 capacity

Convertible Note Raises $3.5 Million to Address Debt

Native Mineral Resources Holdings Limited (ASX:NMR) has locked in a A$3.5 million funding injection via a convertible note agreement with Lind Global Fund III LP, an existing investor. The new note, with a face value of A$3.9375 million, will see part of the proceeds; A$1.127 million; used to repay prior convertible note obligations from January 2026, while the remainder will shore up the company's general working capital and reduce some of its debt burden.

This funding round is structured to provide NMR with flexible capital access, as emphasised by Managing Director Blake Cannavo, who highlighted the value of maintaining a strong partnership with Lind during this growth phase. The arrangement allows the company to manage its near-term financial needs without immediate equity dilution, preserving capacity for future capital raises.

Conversion Terms and Potential Share Dilution

The convertible note carries a six-month redemption window. If NMR does not redeem the note by the repayment date, Lind may convert the note into ordinary shares at a conversion price set at the lower of A$0.15 or 90% of the average of the five lowest daily volume-weighted average prices (VWAP) during the 20 trading days prior to conversion. Additionally, 25 million placement shares will be issued upfront to offset any future conversion shares, all capped within a maximum potential issuance of approximately 71 million shares; representing roughly 6.5% dilution of the company's current issued capital.

The company has confirmed this issuance falls within its existing ASX Listing Rule 7.1 placement capacity, though it may seek shareholder ratification to preserve future placement flexibility. The agreement includes a 3% commitment fee deducted from the funds advanced and customary default provisions, including accelerated repayment and default interest in the event of breach.

Funding Strategy Amid Operational Momentum

This convertible note funding follows a series of operational milestones for NMR, including steady gold production at its Blackjack Mill and ongoing expansion efforts in the Charters Tower region. Recent reports highlighted the company’s ability to leverage the Blackjack Mill across multiple assets, underpinning Lind’s confidence in the operational expertise of the NMR team. The new funding complements prior financing arrangements, such as a $4 million unsecured loan secured earlier in April to fund the Podosky Gold Project acquisition, which avoided equity dilution during a critical funding window.

With mining activities ramping up and exploration programs underway, this capital injection aims to provide the financial runway to support NMR’s growth trajectory without immediate pressure on the share register. The company’s approach reflects a preference for convertible debt instruments over traditional equity raises, citing more favourable commercial terms and alignment with shareholder interests.

Shareholder Approval and Future Capital Considerations

While the note issue is currently within NMR’s placement capacity, the company has flagged the possibility of seeking shareholder approval under Listing Rule 7.4 to retain full flexibility for future capital raising. The actual extent of dilution remains uncertain and will depend on Lind’s election to convert the notes and prevailing market prices at conversion time.

Investors should note the potential for up to 6.5% dilution if full conversion occurs, but also that redemption at face value prior to the repayment date would avoid share issuance altogether. The company has committed to keeping the market informed of material developments, including any conversion notices or additional funding tranches.

Bottom Line?

NMR’s convertible note deal offers short-term financial flexibility while balancing potential dilution risks, setting the stage for its next operational phase.

Questions in the middle?

• Will Lind Global Fund III LP convert the note or seek redemption at face value?
• How will upcoming production and exploration results impact NMR’s capital needs?
• Will shareholder ratification be sought to preserve future placement capacity?